Duchenne muscular dystrophy (DMD) is a muscle degeneration disorder caused by mutations affecting the dystrophin gene. Researchers show how a dual CRISPR RNA method restored dystrophin protein ...
From left: Myosana CEO Matthew Lumley, with co-founders Stanley Froehner and Nick Whitehead. (Myosana and UW Photos) The news: Myosana Therapeutics, a Seattle startup developing gene therapy ...
IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. Fritz Frohse (1871-1916), a physician ...
بعض نتائج کو اس وجہ سے چھپا دیا گیا ہے کیونکہ ممکن ہے آپ کو ان تک رسائی حاصل نہ ہو۔
ناقابل رسائی نتائج دکھائیں۔